CERo Therapeutics Warrants (CEROW)

• Market cap: $1.5K
• 1 day: 8.67%
• 5 days: 7.24%
• 1 month: 13.99%
• 3 months: -18.5%
• 6 months: 31.45%
• Year to date: 63%
• 1 year: 213.46%
• 5 years: -96.87%
• 10 years: -96.87%
• Sector: Healthcare
• Industry: Biotechnology

About: CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.

Employees: 8